Uncertainty and the diagnosis of male infertility: The use of discrete WHO reference thresholds leads to the ‘over-labelling’ of men as subfertile Josephine Salter, Clinical Scientist, NUH Life, UK
Efficacy of the combined use of ICSI and antioxidants on the clinical outcomes of patients with high DNA fragmentation index (DFI) – Violetta Soura, Clinical Embryologist, The Agora Fertility Clinic, Brighton, UK
Dr Violetta Soura is a HCPC registered Clinical Embryologist with a background in Molecular Biology. She obtained her BSc in Molecular Biology at the University of Manchester before completing an MSc in Genetic Manipulation and Molecular Cell Biology at the University of Sussex. In 2009 she was awarded with a PhD in Biochemistry for her research on Motor Neuron Disease. In 2016, following two successful post-doctoral posts, she joined the Agora Fertility team as a Clinical Embryologist. Violetta has an active role in laboratory QMS, cryobank management and research.
RNA-Seq transcriptome profiling of human metaphase II oocytes as a method for assessing the impact of oocyte cryopreservation – Tope Adeniyi, Senior Clinical Embryologist and NIHR Clinical Fellow, Manchester University NHS Foundation Trust, UK
Tope Adeniyi is a senior clinical embryologist and NIHR clinical fellow at the Department of Reproductive Medicine (DRM), Old Saint Mary’s Hospital. After completing a BSc. degree in clinical biochemistry, he attended the University of Leeds where he obtained a MSc. degree in clinical embryology. Following graduation, he joined Midland Fertility Services in 2005 (CARE Fertility, Tamworth) and subsequently DRM in 2009. In 2015, he was awarded the prestigious NIHR clinical doctoral fellowship to investigate the impact of ART methods of cryopreservation on human metaphase II oocyte. His clinical and research interests include embryo culture media, oocyte cryopreservation and gene expression.
Oocytes and embryos are exposed to unnecessary risk during routine fertility cryopreservation and storage – Rachel Gregoire, Scientific Director, Hewitt Fertility Centre, UK
Artificial intelligence versus the embryologist; could the embryologist be replaced by the machine for embryo developmental assessment? – Amy Barrie, Laboratory Manager, CARE Fertility, Chester, UK